Table 4 The clinical baseline characteristics of the VTE and HC groups

Age, Median (IQR)

42 (32, 57)

53 (40, 67)

34 (31, 39)

 < 0.001

Sex, n (%)

 < 0.001

F

90 (60)

42 (47)

48 (80)

M

59 (40)

47 (53)

12 (20)

FVL genotype, n (%)

1

GG

149 (100)

89 (100)

60 (100)

PAI-1 genotype, n (%)

0.064

4G/4G

51 (34)

35 (39)

16 (27)

4G/5G

72 (48)

36 (40)

36 (60)

5G/5G

26 (17)

18 (20)

8 (13)

RBC, × 10¹²/L, Median (IQR)

4.36 (4.08, 4.69)

4.33 (3.91, 4.77)

4.41 (4.23, 4.63)

0.207

Hb, g/L, Median (IQR)

134 (122, 144)

133.5 (117, 146)

134.5 (126, 142.25)

0.314

HCT, %, Mean ± SD

38.8 ± 4.85

38.72 ± 5.85

38.92 ± 2.83

0.778

WBC, × 10⁹/L, Median (IQR)

5.95 (5.15, 7.28)

6.54 (5.3, 8.95)

5.77 (4.87, 6.25)

0.001

L, × 10⁹/L, Mean ± SD

1.62 ± 0.55

1.56 ± 0.63

1.72 ± 0.38

0.049

N, × 10⁹/L, Median (IQR)

3.7 (2.91, 5.11)

4.16 (3.15, 6.47)

3.51 (2.77, 3.87)

 < 0.001

PLT, × 10⁹/L, Median (IQR)

218 (187.75, 260.75)

211.5 (160.75, 276)

224.5 (197.75, 256)

0.197

NLR, Median (IQR)

2.15 (1.7, 3.2)

2.59 (1.92, 4.8)

1.99 (1.61, 2.34)

 < 0.001

PLR, Median (IQR)

138.23 (104.54, 177.2)

139.86 (98.16, 202.84)

135.53 (111.71, 164.29)

0.362